Your browser doesn't support javascript.
loading
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.
van de Merbel, Arjanneke F; van der Horst, Geertje; van der Mark, Maaike H; Bots, Selas T F; van den Wollenberg, Diana J M; de Ridder, Corrina M A; Stuurman, Debra; Aalders, Tilly; Erkens-Schulz, Sigrun; van Montfoort, Nadine; Karthaus, Wouter R; Mehra, Niven; Smits, Minke; Schalken, Jack A; van Weerden, Wytske M; Hoeben, Rob C; van der Pluijm, Gabri.
Afiliação
  • van de Merbel AF; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Horst G; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Mark MH; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bots STF; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Wollenberg DJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Ridder CMA; Department of Experimental Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Stuurman D; Department of Experimental Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Aalders T; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Erkens-Schulz S; Department of Experimental Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van Montfoort N; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Karthaus WR; Human Pathology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Smits M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Weerden WM; Department of Experimental Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Hoeben RC; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Pluijm G; Department of Urology, Leiden University Medical Center, Leiden, The Netherlands. g.van_der_pluijm@lumc.nl.
Cancer Gene Ther ; 29(6): 793-802, 2022 06.
Article em En | MEDLINE | ID: mdl-34135475
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Reoviridae / Orthoreovirus Mamífero 3 / Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Animals / Humans / Male Idioma: En Revista: Cancer Gene Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Reoviridae / Orthoreovirus Mamífero 3 / Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Animals / Humans / Male Idioma: En Revista: Cancer Gene Ther Ano de publicação: 2022 Tipo de documento: Article